Literature DB >> 20001154

Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid.

P López-Serrano1, J L Pérez-Calle, E Carrera-Alonso, T Pérez-Fernández, G Rodríguez-Caravaca, D Boixeda-de-Miguel, C M Fernández-Rodríguez.   

Abstract

INTRODUCTION: The incidence of inflammatory bowel disease (IBD) varies widely according to geographical area and has been reported to have increased in the last few years. No data are available on the current incidence of this disease in Madrid (Spain). AIM: to determine the incidence of inflammatory bowel disease in the area of influence of University Hospital Fundación Alcorcón (Madrid), and to compare our results with those from other Spanish and European series. PATIENTS AND METHODS: A prospective, population-based study was performed to determine the incidence of IBD in the area of University Hospital Fundación Alcorcón in Madrid between 2003 and 2005. Total population: 213,587 inhabitants (177,490 older than 14 years). Crude rates and age- and sex-specific rates adjusted to the European standard population were calculated. A retrospective study (1998-2003) was also performed.
RESULTS: A total of 69 cases were diagnosed -Crohn s disease (CD): 35, ulcerative colitis (UC): 33, indeterminate colitis: 1- in the prospective period. Crude rates of CD and UC were 7.92 and 7.47 cases/100,000 inhabitants/year, respectively (the population aged 0-14 years). Specific rates were 8.0 (95% CI, 7.03-8.97) and 7.47 (95% CI, 6.5-8.4), respectively. Mean age at diagnosis was 31.02+/- 10.76 and 39.91+/-16.19 years for CD and UC, respectively. Incidence in the retrospective study was 7.13 and 6.22 cases/100,000 inhabitants/year, respectively for CD and UC.
CONCLUSIONS: The incidence of CD and UC in Madrid has increased in the last decades, with rates close to those in northern European countries for CD, higher than those recently published in Spanish prospective studies and similar to those previously described in Spain and southern countries for UC. Rates were higher in the prospective period than in the retrospective one.

Entities:  

Mesh:

Year:  2009        PMID: 20001154     DOI: 10.4321/s1130-01082009001100004

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  8 in total

Review 1.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

2.  Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens.

Authors:  Janka Bábíčková; Ľubomíra Tóthová; Eva Lengyelová; Anastázie Bartoňová; Július Hodosy; Roman Gardlík; Peter Celec
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

3.  Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).

Authors:  Ignacio Marín-Jiménez; Cristina Saro; Verónica Díaz; Manuel Barreiro-de Acosta; María Gómez-García; Ana Gutiérrez Casbas
Journal:  Drugs Context       Date:  2018-03-06

4.  EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Authors:  María Chaparro; Manuel Barreiro-de Acosta; José Manuel Benítez; José Luis Cabriada; María José Casanova; Daniel Ceballos; María Esteve; Hipólito Fernández; Daniel Ginard; Fernando Gomollón; Rufo Lorente; Pilar Nos; Sabino Riestra; Montserrat Rivero; Pilar Robledo; Cristina Rodríguez; Beatriz Sicilia; Emilio Torrella; Ana Garre; Esther García-Esquinas; Fernando Rodríguez-Artalejo; Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2019-05-21       Impact factor: 4.409

5.  Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases.

Authors:  Francisco J Martinez-Orozco; Miguel Fernandez-Arquero; Jose L Vicario; Laura Lillo-Triguero; Elena Ameyugo; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2022-08-27

Review 6.  Incidence and paris classification of pediatric inflammatory bowel disease.

Authors:  Katalin Eszter Müller; Peter Laszlo Lakatos; Maria Papp; Gabor Veres
Journal:  Gastroenterol Res Pract       Date:  2014-03-20       Impact factor: 2.260

7.  Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.

Authors:  Francisco Javier Martinez-Orozco; Jose Luis Vicario; Clara De Andres; Miguel Fernandez-Arquero; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2016-05-29

8.  Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients.

Authors:  Mohammed Al Fadda; Musthafa Chalikandy Peedikayil; Ingvar Kagevi; Khalid Al Kahtani; Ali Al Ben; Hamad Ibrahim Al; Fahad Al Sohaibani; Mohammed Al Quaiz; Maheeba Abdulla; Mohammed Qaseem Khan; Ahmed Helmy
Journal:  Ann Saudi Med       Date:  2012 May-Jun       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.